Health News Archive - August 02, 2010

GREENSBORO, N.C., Aug. 2 /PRNewswire/ -- Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm.

MOBILE, Ala., Aug. 2 /PRNewswire-FirstCall/ -- Hasco Medical, Inc.

Funds to Strengthen Financial Health of Local Community Organizations DETROIT, Aug. 2 /PRNewswire-USNewswire/ -- Nonprofit Finance Fund (NFF) has been awarded $1 million from Trinity Health in Novi, Michigan, to improve the access to capital for Michigan nonprofits.

WOONSOCKET, R.I., Aug. 2 /PRNewswire/ -- It's time for back-to-school physicals and immunizations, but it's not just for children.

WALTHAM, Mass., Aug. 2 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today announced that the Company has received three additional grants to support its research program to develop HDAC inhibitors for neurodegenerative diseases.


Within 24 hours of culturing adult human stem cells on a new type of matrix, University of Michigan researchers were able to make predictions about how the cells would differentiate, or what type of tissue they would become.

Local Ordinance will help City Recover $17.7 Million in Alcohol-Related Health Care Costs SAN FRANCISCO, Aug.